Quarterly report pursuant to Section 13 or 15(d)

Aero Acquisition (Details Narrative 2)

v2.4.0.6
Aero Acquisition (Details Narrative 2) (Aero Pharmaceuticals, Inc. ("Aero"), USD $)
0 Months Ended
May 16, 2011
Intangible assets acquired $ 282,800
Useful life of intengible assets acquired 5 years
Acquired brands
 
Intangible assets acquired 110,000
Customer relationships
 
Intangible assets acquired $ 172,800